Robert Hershberg, Director at Adaptive Biotechnologies, holds 46.68K shares in Adaptive Biotechnologies (Ticker: ADPT), holds 10.66K shares in Fate Therapeutics (Ticker: FATE), holds ― shares in ARS Pharmaceuticals (Ticker: SPRY).
Robert Hershberg latest transaction was an Uninformative Buy of $94.80K.
What was Robert Hershberg's most profitable transaction?
Robert Hershberg’s most profitable transaction was an Informative Sell of HLVX stock on February 12, 2024. The return on the trade was 88.70%.
What is Robert Hershberg's role in Adaptive Biotechnologies?
Robert Hershberg's role in Adaptive Biotechnologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.